Ryan Confer, Chief Financial Officer at Genprex, discusses gene therapies for cancer and diabetes with Jane King

Innovators with Jane King profiles tech companies and thought leaders in the space. Genprex (NASDAQ: GNPX): is focused on developing life-changing therapies for cancer & diabetes patients.